Grupo 3
Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético
Publicaciones (557)
-
Domingo-Gonzalez, A; Regalado-Artamendi, I; Martin-Rojas, RM; Perez-Rus, G; Perez-Corral, A; Diez-Martin, JL; Pascual-Izquierdo, C.
Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at a tertiary care facility in Spain
JOURNAL OF CLINICAL APHERESIS. 2021; 36(3): 420-428 Nº de citas: 7 [doi:10.1002/jca.21880]
-
Pascual, C; Nieto, JM; Fidalgo, T; Segui, IG; Diaz-Ricart, M; Docampo, MF; del Rio, J; Salinas, R.
Multicentric evaluation of the new HemosIL Acustar(R) chemiluminescence ADAMTS13 activity assay
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2021; 43(3): 485-493 Nº de citas: 11 [doi:10.1111/ijlh.13414]
-
Sanz, J; Galimard, JE; Labopin, M; Afanasyev, B; Sergeevich, MI; Angelucci, E; Kroger, N; Koc, Y; Ciceri, F; Diez-Martin, JL; Arat, M; Sica, S; Rovira, M; Aljurf, M; Tischer, J; Savani, B; Ruggeri, A; Nagler, A; Mohty, M.
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
JOURNAL OF HEMATOLOGY & ONCOLOGY. 2021; 14(1): Nº de citas: 34 [doi:10.1186/s13045-021-01094-2]
-
Puig, N; Hernandez, MT; Rosinol, L; Gonzalez, E; de Arriba, F; Oriol, A; Gonzalez-Calle, V; Escalante, F; de la Rubia, J; Gironella, M; Rios, R; Garcia-Sanchez, R; Arguinano, JM; Alegre, A; Martin, J; Gutierrez, NC; Calasanz, MJ; Martin, ML; Couto, MD; Casanova, M; Arnao, M; Perez-Persona, E; Garzon, S; Gonzalez, MS; Martin-Sanchez, G; Ocio, EM; Coleman, M; Encinas, C; Vale, AM; Teruel, AI; Cortes-Rodriguez, M; Paiva, B; Cedena, MT; San-Miguel, JF; Lahuerta, JJ; Blade, J; Niesvizky, R; Mateos, MV.
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Blood Cancer Journal. 2021; 11(5): 101-101 Nº de citas: 15 [doi:10.1038/s41408-021-00490-8]
-
Bailen, R; Vicario, JL; Solan, L; Sanchez-Vadillo, I; Herrera, P; Calbacho, M; Alenda, R; Lopez-Lorenzo, JL; Humala, K; Chinea, A; Sanchez-Pina, J; Balas, A; Moreno, MA; Arzuaga, J; Pradillo, V; Dorado, N; Oarbeascoa, G; Anguita, J; Diez-Martin, JL; Kwon, M; AMHH.
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Frontiers in Immunology. 2021; 12: 674658-674658 Nº de citas: 12 [doi:10.3389/fimmu.2021.674658]
-
Giebel, S; Labopin, M; Socie, G; Beauvais, D; Klein, S; Wagner-Drouet, EM; Blaise, D; Nguyen-Quoc, S; Bourhis, JH; Thiebaut, A; Labussiere-Wallet, H; Charbonnier, A; Berceanu, A; Diez-Martin, JL; Fegueux, N; Esteve, J; Nagler, A; Mohty, M.
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT
BONE MARROW TRANSPLANTATION. 2021; 56(5): 1047-1055 Nº de citas: 4 [doi:10.1038/s41409-020-01139-z]
-
Oreiro, MB; Martin, R; Gomez, P; Munoz, NL; Rodriguez, A; Liebana, M; Navarro, B; Sanchez-Gonzalez, B; Mari, P; de Oteiza, JP; Gutierrez, A; Bento, L; Domenech, ED; Vidal, MJ; Del Campo, R; Ceballos, EP; Infante, M; Roldan, A; Belmonte, DG; Santero, M; Sureda, A; Sanz, RG; GELTAMO Grp.
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment
Cancers. 2021; 13(10): Nº de citas: 1 [doi:10.3390/cancers13102412]
-
Fernandez, CM; Feltrin, MZ.
Second Osteosarcoma in a 16-Year-old Woman Diagnosed With Rothmund-Thomson Syndrome
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2021; 43(4): 532-534 Nº de citas: 1 [doi:10.1097/MPH.0000000000001884]
-
Solves, P; Lozano, M; Zhiburt, E; Velasco, JA; Perez-Corral, AM; Monsalvo-Saornil, S; Yamazaki, S; Okazaki, H; Selleng, K; Aurich, K; Kruger, W; Buser, A; Holbro, A; Infanti, L; Stehle, G; Pierelli, L; Matteocci, A; Rigacci, L; De Vooght, KMK; Kuball, JHE; Fielding, KL; Westerman, DA; Wood, EM; Cohn, CS; Johnson, A; Koh, MBC; Qadir, D; Cserti-Gazdewich, C; Daguindau, E; Angelot-Delettre, F; Tiberghien, P; Wendel-Neto, S; Fachini, RM; Morton, S; Craddock, C; Lumley, M; Antoniewicz-Papis, J; Halaburda, K; Letowska, M; Dunbar, N.
International Forum on Transfusion Practices in Haematopoietic Stem-Cell Transplantation: Responses
VOX SANGUINIS. 2021; 116(5): 25-43 Nº de citas: 1 [doi:10.1111/vox.13021]
-
Iacoboni, G; Villacampa, G; Martinez-Cibrian, N; Bailen, R; Corral, LL; Sanchez, JM; Guerreiro, M; Caballero, AC; Mussetti, A; Sancho, JM; Hernani, R; Abrisqueta, P; Solano, C; Sureda, A; Briones, J; Garcia-Sancho, AM; Kwon, M; Reguera-Ortega, JL; Barba, P.
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Cancer Medicine. 2021; 10(10): 3214-3223 Nº de citas: 104 [doi:10.1002/cam4.3881]
-
Inusa, BPD; Inati, A; Maes, P; Githanga, J; Ogutu, B; Abboud, MR; Miano, M; Cela, E; Nduba, V; Niazi, M; Astrand, M; Persson, K; Berggren, A; Carlson, G.
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months
PEDIATRIC BLOOD & CANCER. 2021; 68(5): Nº de citas: 2 [doi:10.1002/pbc.28977]
-
Murillo-Sanjuan, L; Gonzalez-Vicent, M; Aparicio, BA; Serra, IB; Villa, AR; Oficialdegui, MLU; Lopez-Duarte, M; Belendez-Bieler, C; Urgelles, AS; Navarro, JS; Diaz-de-Heredia, C; Spanish Soc Pediat Hematology Onco.
Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children
BONE MARROW TRANSPLANTATION. 2021; 56(5): 1213-1216 Nº de citas: 6 [doi:10.1038/s41409-020-01172-y]
-
Casella, JF; Barton, BA; Kanter, J; Black, LV; Majumdar, S; Inati, A; Wali, Y; Drachtman, RA; Abboud, MR; Kilinc, Y; Fuh, BR; Al-Khabori, MK; Takemoto, CM; Salman, E; Sarnaik, SA; Shah, N; Morris, CR; Keates-Baleeiro, J; Raj, A; Alvarez, OA; Hsu, LL; Thompson, AA; Sisler, IY; Pace, BS; Noronha, SA; Lasky, JL; de Julian, EC; Godder, K; Thornburg, CD; Kamberos, NL; Nuss, R; Marsh, AM; Owen, WC; Schaefer, A; Tebbi, CK; Chantrain, CF; Cohen, DE; Karakas, Z; Piccone, CM; George, A; Fixler, JM; Singleton, TC; Moulton, T; Quinn, CT; Lobo, CLD; Almomen, AM; Goyal-Khemka, M; Maes, P; Emanuele, M; Gorney, RT; Padgett, CS; Parsley, E; Kronsberg, SS; Kato, GJ; Gladwin, MT.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2021; 325(15): 1513-1523 Nº de citas: 33 [doi:10.1001/jama.2021.3414]
-
Carbonell, D; Suarez-Gonzalez, J; Chicano, M; Andres-Zayas, C; Diez-Diez, M; Rodriguez-Macias, G; Muniz, P; Kwon, M; Anguita, J; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
LEUKEMIA & LYMPHOMA. 2021; 62(5): 1178-1186 Nº de citas: 1 [doi:10.1080/10428194.2020.1863400]
-
Ribera, JM; Morgades, M; Ciudad, J; Montesinos, P; Esteve, J; Genesca, E; Barba, P; Ribera, J; Garcia-Cadenas, I; Moreno, MJ; Martinez-Carballeira, D; Torrent, A; Martinez-Sanchez, P; Monsalvo, S; Gil, C; Tormo, M; Artola, MT; Cervera, M; Gonzalez-Campos, J; Rodriguez, C; Bermudez, A; Novo, A; Soria, B; Coll, R; Amigo, ML; Lopez-Martinez, A; Fernandez-Martin, R; Serrano, J; Mercadal, S; Cladera, A; Gimenez-Conca, A; Penarrubia, MJ; Abella, E; Vall-llovera, F; Hernandez-Rivas, JM; Garcia-Guinon, A; Bergua, JM; de Rueda, B; Sanchez-Sanchez, MJ; Serrano, A; Calbacho, M; Alonso, N; Mendez-Sanchez, JA; Garcia-Boyero, R; Olivares, M; Barrena, S; Zamora, L; Granada, I; Lhermitte, L; Feliu, E; Orfao, A.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia
BLOOD. 2021; 137(14): 1879-1894 Nº de citas: 65 [doi:10.1182/blood.2020007311]
-
Santos, A; Macias, N; Vega, A; Abad, S; Linares, T; Aragoncillo, I; Cruzado, L; Pascual, C; Goicoechea, M; Lopez-Gomez, JM.
Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
CLINICAL KIDNEY JOURNAL. 2021; 14(4): 1120-1125 Nº de citas: 9 [doi:10.1093/ckj/sfaa057]
-
Galvez, E; Vallespin, E; Arias-Salgado, EG; Sanchez-Valdepenas, C; Gimenez, Y; Navarro, S; Rio, P; Bogliolo, M; Pujol, R; Peiro, M; Nevado, J; Zubicaray, J; Sebastian, E; Catala, A; Belendez, C; de Heredia, CD; Galera, A; Badell, I; Madero, L; Perona, R; Sastre, L; Surralles, J; Bueren, J; Lapunzina, P; Sevilla, J.
Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes
Hemasphere. 2021; 5(4): Nº de citas: 10 [doi:10.1097/HS9.0000000000000539]
-
Cid, J; Monsalvo, S; Castillo, C; Pascual, C; Moreno-Jim, G; Lopez-Parra, M; Andon, C; Guerra, L; Esquirol, A; Sanchez-Ortega, I; Ortega, S; Zalba, S; Martinez, C; Rovira, M; Marin, P; Lozano, M.
Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Espanol de Trasplante Hematopoyetico (GETH)
TRANSFUSION AND APHERESIS SCIENCE. 2021; 60(2): 103052-103052 Nº de citas: 10 [doi:10.1016/j.transci.2021.103052]